Home » Topics » Elixir Companies

Elixir Companies

    London: The UK company, Transdermal Cosmetics Ltd, a wholly owned subsidiary of Transdermal Sciences PLC, is to float on the UK's AIM stockmarket later this year. It has plans to bring several anti-ageing products to the consumer market, based on the parent company's patented "somazone” technology. Somazone is a technology that effectively shrinks the large molecules in active ingredients, such as collagen, so that they can be more easily absorbed beneath the skin’s surface. The company also plans to make the technology available to cosmetic and pharmas in the same way as fabric manufacturers are able to incorporate Lycra...
    US wrinkle market turns ugly in battle to save faces In only five years Botox, has literally changed the face of wrinkles and the fortunes of its US manufacturer Allergan Inc. But its stranglehold on the neurotoxin market may be coming to an end. Arizona based Medicis Pharmaceutical Corp., which sells the No 1 filler Restylane in the US, recently bought its own neurontoxin, Reloxin, which is undergoing patient trials and says it will bring it to the market in 2008 Likewise Allergan is also in the process of rolling out its own dermal filler, Juvederm which it recently...
    London: Rising demand for anti-wrinkling cream helped Croda, the speciality chemical company, to boost half-year profits by 11 per cent. Mike Humphrey, chief executive, said demand continued to be underpinned by "the desire to be beautiful in today's society" - the group produces ingredients for anti-ageing products of Estee Lauder and Unilever. Croda said that sales in its core consumer care division had risen by 8.2 per cent in the six months to June 30. Pre-tax profits for the half-year were Pounds 27.9m (Pounds 25.1m) as turnover rose by 6.5 per cent to Pounds 164.5m. Earnings per share were up...
    New York: USA-based Allergan says that its diluted earnings per share for the second quarter of 2006 reached $0.49, a massive 96% increase on the like, year-ago period, as its total net product sales jumped 32% to $787.0 million. This includes $128.3 million of revenue acquired from its $3.1 billion purchase of Inamed (Marketletter April 3). Excluding special items, Allergan made $0.86 per share during the reporting period, beating the $0.85 average from a poll by Reuters Estimates. The firm's sales also exceeded the consensus average of $763.0 million. During the period, pharmaceutical sales increased 17.9%, or 17.4% at constant...
    Cosmetics giant Revlon has confirmed that its preliminary Q2 results have been hit by weaker than expected sales of its news Vital Radiance cosmetic range for older women. The company had been banking on a big take-up for the range, aimed at the 50-plus category. But despite the huge increase in sales of cosmetic products aimed at the graying baby boomer generation, Revlon’s new range appears to have missed the mark. The company said that it is expecting to incur losses of $95m for the most recent quarter, as opposed to losses of $35m in the corresponding quarter last year....
    Avon Products has announced a significant drop in its profits as restructuring charges hit the bottom line and the company’s performance in most markets, including the US, came in below expectations. The company said that during its second quarter, net income dropped 54 per cent to reach $150.9m on the back $2.1bn in sales, up 5 per cent on the same period last year. The company said that it incurred a $49m charge, as part of its massive restructuring programme, introduced in the last quarter of 2005. These costs included organisational realignments and a reduction in the workforce, particularly in...
    Johnson & Johnson is rumoured to be in advanced talks to buy up Beijing-based Dabao Cosmetics – a move that could give the company a valuable footing in what is currently a huge growth market. According to reports in the Shanghai Oriental Morning Post, an industry insider said that the companies have made an agreement with regards the sale that is now undergoing regulatory approval. Niether company has confirmed or denied the press reports, but with state regulatory approval of buy-outs involving foreign companies often proving to be a long and arduous process, it may be some time before the...
    A jump of 27 per cent in sales of its skin care care products helped to boost quarterly profits at Playtex Products, encouraging the company to reiterate its full-year forecasts. During the latest quarter to July 1, the company said that net sales were up 10 per cent to reach $180.3m, compared to $163.8m in the corresponding quarter for 2005. On the back of this net income rose to $10.3m, compared to the $6.2m recorded for the same period last year. Including charges and gains net profit totaled $11m, compared to $8.9m in the corresponding quarter of 2005. Both sales...
    First Book on How to Make Money Investing in Nanotechnology Released June 2005: www.nanotechnology.com[The Nanotech Company] is pleased to release the first book on how to make money investing in nanotechnology and other so-called “small technologies,” titled "Nanotech Fortunes." Authored by the company’s founder and managing director Darrell Brookstein, a 32-year career investment professional, author-personalized first-editions of the 256 page hardcover book are only available at the company’s website, www.nanotechnology.com for a discounted $22.95 (retail $27.95). Best current price for the new book is at www.atlasbooks.com where it appears for $18.45. Mr. Brookstein is a Duke University graduate who went...
    NEW YORK, May 4: Elizabeth Arden, Inc.(Nasdaq: RDEN), a global prestige beauty products company, has entered into anexclusive co-marketing agreement with Allergan, Inc., a specialtypharmaceutical company and market leader in dermatology. Allergan is the maker of Botox(R) Cosmetic, currently the No. 1 non-surgical cosmeticprocedure in the United States, and M.D.Forte(R), a leading physician-dispensed skincare line in the United States. The agreement teams Elizabeth Arden's expertise in the prestige skincare industry with Allergan's leadership in dermatology. The partnership will bring a newly formulated PREVAGE(TM) to prestige cosmetic retailers worldwide through Elizabeth Arden. The new formulation will contain 0.5% idebenone, a patented,...
    Epi Tan is an Australian pharmaceutical company that specialises in dermatology treatments. It launched on the UK's AIM in May 2005. Epi Tan has developed a synthetic version of the naturally occuring hormone alpha-MSH, which stimulates melanin production. Melanin helps protect the skin against sunburn by increasing pigment. Early clinical trials have shown a reduction in sunburn injury by up to 50 per cent. Called Melanontan, it is injected in a slow release form but a lotion and spray are being trialed. The company is also listed on the Australian Stock Exchange....
    Clarins OVERVIEW Some people say that French women are born beautiful. Clarins prefers that women, instead, place their faith in its upscale skin care products, makeup, and perfume. The company touts ingredients such as herbal and marine extracts and air-pollution-defying complexes in its products, which are sold through department and specialty stores in Asia, Europe, and the US. The company targets skin-conscious consumers with antiwrinkle and firming creams. Clarins also serves the sweet-smelling fragrance market; its top scents include Angel and Azzaro's Azzura. Founder Jacques Courtin-Clarins and his family control the company.Clarins sells its products primarily through pharmacies, department stores,...
    Health Anti-Aging Lifestyle Options, Inc. Health Anti-Aging Lifestyle Options (HALO) is a multimedia marketing company that offers health, wellness, and anti-aging programs and products. The company's HALO media program is intended for home-based entrepreneurs; HALO offers products to "maximize human potential" and enhance the entrepreneur's financial and physical life. Programs feature host Jesse Dylan and include interviews with popular endocrinologist Dr. Deepak Chopra, Real Age author Dr. Michael Roizen, Oprah fitness guru Bob Greene, and psychic Sylvia Browne. The company was founded as Daur & Shaver in 1986; its name was changed to HALO in anticipation of the 2003 near-buyout...
    L'Occitane, pronounced "lox-ee-tahn," gets its name from the ancient province that once stretched across the south of France. The company, founded in 1976, manufactures body and skin care, men's grooming items, hair care, and home fragrance products incorporating natural ingredients from the Provence area. L'Occitane owns Olivier & Co., an olive oil producer and retailer, and operates subsidiaries in the US, Hong Kong, and the UK. Products, most of which have Braille labeling, include Precious Cream from Immortelle (anti-aging), shea butter lip balm and hand cream, orange nutmeg incense sticks, Lavender Harvest fragrance, and the L'Oranger line. Clarins holds a...
    2005 FEB 4 - Senetek PLC (SNTKY), a healthcare technologies company engaged in developing products for the anti-aging market, announced positive results from its initial multi-faceted study of the effects of an adenine derivative, Zeatin, and 2 other new compounds representing new cytokinin classifications, AK801 and PRK124. The study was conducted over a 3-week period at the Department of Dermatology, University of California at Irvine using the hairless mouse model. This study model is designed to evaluate new compounds for safety and efficacy in the potential treatment of skin anti-aging and to investigate the mechanisms by which they affect the...
    About Lifeline Therapeutics Lifeline Therapeutics, Inc. is a publicly-traded company (OTC Bulletin Board: LFLT)based in Denver, Colorado, that is dedicated to the manufacture, marketing and distribution of therapies that promote "healthy life expectancy." The Company is initially focusing exclusively on unique antioxidant products under its Protandim brand and in the future will develop an array of product candidates for nutraceutical, pharmaceutical and cosmeceutical applications. To underscore the Company's commitment to higher quality of life and healthy life expectancy, Lifeline Therapeutics has pledged 10% of its pre-tax profits to support orphanages and other global humanitarian needs. www.lifelinenutraceuticals.com...
    UK's Biocompatibles in deal to combat ageing LONDON, March 4 - Britain's Biocompatibles International (BII.L) agreed to buy Germany's CellMed AG for up to 22.2 million euros ($29.3 million) on Friday, gaining access to an experimental Botox-style drug to combat ageing. Biocompatibles, which focuses on the treatment of heart disease and cancer, said it would pay an initial sum of 5.2 million euros, including 3.0 million in cash and the rest in Biocompatibles shares. Of the maximum consideration, around 70 percent is payable in Biocompatibles shares and the rest in cash. Both firms specialise in bead technology, in which a...
    Dermacia Inc. Successfully Raises $10 Million to Date in First Round of Private Funding; Gemini Partners Engaged to Explore Additional Financing Opportunities for Cosmeceutical/Skin Care Company NEWPORT BEACH, Calif, May 19, 2005--Dermacia Inc. today announced that it has raised $10 million since commencing its first round of private funding and that Gemini Partners, Inc., a Los Angeles-based investment banking group, has been engaged to explore additional opportunities to finance Dermacia's rapid growth and new product initiatives. The Company recently announced the introduction of a new line of specialized cosmeceutical products designed for a mass worldwide market, augmenting its proprietary Lycogel(TM)...
    The health, pharmaceutical and cosmetics sectors offer a vast array of opportunities for investors. Scientists are making discoveries that save countless lives and eradicate ageing diseases. These opportunites are being commercially exploited by the pharmaceutical and cosmetic industries. ElixirNews believes that since you, the consumer, are spending your hard-earned cash in this sector that you should also know about the possibilities for investing and getting your money back. We will therefore be reporting on companies of interest in this sector. We are not investment advisors and are not giving investment advice. You should consult a qualified professional investment broker for...

A large percentage of of what you say is astonishingly legitimate and it makes me wonder why I had not looked at this in this light previously. This piece truly did turn the light on for me as far as this specific issue goes. But there is one position I am not necessarily too cozy with and while I attempt to reconcile that with the core idea of the point, let me observe exactly what all the rest of the subscribers have to point out.Well done.

I prefer to look on the brighter side of things which I'm sure you can appreciate.

I was looking through StumbleUpon for sites on this very issue so I really appreciate your well written article. I enjoyed your writing style and have subscribed to your feed so I can catch, not miss future posts on this and other topics.

Can I just say what a relief to find someone who actually knows what theyre talking about on the internet. You definitely know how to bring an issue to light and make it important. More people need to read this and understand this side of the story. I cant believe youre not more popular because you definitely have the gift.

Nice little blog and very easy to navigate. Got it bookmarked and will try to remember to visit again.

Wow, awesome blog layout! How long have you been blogging for? you made blogging look easy. The overall look of your web site is great, let alone the content!

I like Your Article about Elixirnews - Guy's Eye Perfect just what I was searching for! .

Interesting knowledge. I have been previously looking for a site with content just as this. Thanks for giving out :)

thank you for sharing Elixirnews - Guy's Eye with us, I think Elixirnews - Guy's Eye truly stands out : D.

Looking forward to reading more. Great blog post. Really Great.